Reports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full YearGenerated Record $210.2 Million in Full Year Operating Cash FlowReturned Value to Shareholders Through Repurchase of Approximately 6.5 Million Shares To Date Under Recent AuthorizationIssues Financial Guidance for 2026, Reflecting Tenth Consecutive Year of Revenue Growth NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health an ...

Core Insights - Progyny, Inc. will report its financial results for the fourth quarter and full year ended December 31, 2025, on February 26, 2026, after market close [1] - A conference call will be held at 4:45 p.m. Eastern Time to discuss the results, with a press release issued prior to the call [1] - The company is recognized as a leader in women's health and family building solutions, serving major employers and health plans [4] Financial Reporting - The financial results will cover the quarterly period and full year ending December 31, 2025 [1] - Participants can access the conference call via specific dial-in numbers for U.S. and international callers [2] - An audio replay of the call will be available until March 5, 2026 [2] Company Overview - Progyny is headquartered in New York City and has received multiple accolades for its growth and influence in the healthcare sector [6] - The company offers a benefits solution that includes concierge support, coaching, education, and access to a network of fertility and women's health specialists [5] - Progyny aims to provide comprehensive and inclusive solutions that benefit employers, patients, and physicians [4]

Core Insights - Progyny, Inc. will report its financial results for the quarter ending September 30, 2025, on November 6, 2025, after market close [1] - A conference call will be held at 4:45 PM Eastern Time to discuss the financial results [1] - The company is recognized as a leader in women's health and family building solutions, serving major employers and health plans [4][6] Financial Reporting - Financial results will be announced via a press release prior to the conference call [1] - Participants can access the conference call through specific dialing instructions provided for both U.S. and international participants [2] Company Overview - Progyny is a global leader in women's health and family building solutions, aiming to help individuals achieve their family and health goals [4] - The company offers a benefits solution that includes concierge support, coaching, education, and access to a network of fertility and women's health specialists [5] - Progyny has received multiple accolades for its growth and influence in the healthcare sector, including recognition from TIME, CNBC, and Forbes [6]

Core Insights - Progyny, Inc. has appointed Elizabeth Bierbower to its Board of Directors, enhancing its leadership team with her extensive healthcare experience [1][2] - Bierbower has over 30 years of experience in the healthcare industry, having held significant roles in major health plans and provider services [2][3] - The company aims to expand its women's health and family building solutions, focusing on delivering value to members, clients, and shareholders [2][4] Company Overview - Progyny is recognized as a global leader in women's health and family building solutions, serving leading employers and health plans [5][7] - The company provides comprehensive benefits solutions that include concierge support, education, and access to a network of specialists, driving optimal clinical outcomes and reducing healthcare costs [6][5] - Progyny has received multiple accolades for its growth and influence, including being named a TIME100 Most Influential Company and a CNBC Disruptor 50 [7] Leadership and Strategy - Elizabeth Bierbower's leadership experience includes roles at Friday Health Plans and Humana, where she held various senior positions [2][3] - Her appointment is expected to support Progyny's strategy to innovate and expand its product offerings in women's health [2][4] - Bierbower expressed enthusiasm about joining Progyny at a pivotal time for the company's growth and commitment to high-quality care [4]

Core Insights - Progyny has appointed Melissa Cummings as the first Chief Operating Officer (COO) and Geoffrey Clapp as the first Chief Product Officer (CPO) to enhance operational excellence and innovation in women's health and family building [1][2] - The company serves over 530 leading employers, covering 6.7 million contracted lives, and continues to evolve its offerings, including the new Parent and Child Well-being program and doula support [4] Leadership Appointments - Melissa Cummings brings 30 years of healthcare experience, previously serving as Executive Vice President and Chief Customer Officer at Blue Cross & Blue Shield of Rhode Island [2][3] - Geoffrey Clapp has over two decades of experience in healthcare technology and product development, previously leading strategy at Optum Health Solutions [3][4] Company Vision and Strategy - Progyny aims to set a new standard in healthcare with its unique model and commitment to high-touch care, addressing care gaps in women's health [3] - The leadership team is focused on scaling Progyny's mission and impact, anticipating future member needs while delivering immediate value [4] Market Position - Progyny is recognized as a leader in women's health and family building solutions, trusted by major employers and health plans [6][7] - The company has received multiple accolades, including being named a TIME100 Most Influential Company and a CNBC Disruptor 50 [7][8]